
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) stock is trading lower after the company reported third-quarter earnings.
Alnylam also said that it received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts seeking documents about government price reporting for Amvuttra, Onpattro, Oxlumo and Givlaari, including certain fee and discount arrangements with distributors.